Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advent Technologies A | ADN | Aug 30, 2024 | 3.00 | +1.35 |
Adverum Biotechnologies | ADVM | Aug 30, 2024 | 6.94 | +0.87 |
AdvisorShares Pure US Cannabis ETF | MSOS | Aug 30, 2024 | 6.32 | +2.76 |
Advisorshares Star Global Buy-Write ETF | VEGA | Aug 30, 2024 | 43.31 | +0.16 |
AECOM | ACM | Aug 30, 2024 | 100.14 | +0.61 |
Aegon N.V ADR | AEG | Aug 30, 2024 | 6.11 | +0.16 |
Aehr Test Systems | AEHR | Aug 30, 2024 | 15.21 | +1.74 |
Aemetis | AMTX | Aug 30, 2024 | 2.46 | -1.20 |
Aeon Biopharma | AEON | Aug 30, 2024 | 0.83 | -12.12 |
AerCap Holdings | AER | Aug 30, 2024 | 97.42 | +0.91 |
Aeries Technology | AERT | Aug 30, 2024 | 1.91 | +2.69 |
Aerospace & Defense Powershares | PPA | Aug 30, 2024 | 113.50 | +0.85 |
Aerovate Therapeutics | AVTE | Aug 30, 2024 | 1.93 | +4.32 |
AeroVironment | AVAV | Aug 30, 2024 | 203.76 | +0.07 |
AerSale | ASLE | Aug 30, 2024 | 5.09 | -1.17 |
AES | AES | Aug 30, 2024 | 17.13 | -0.75 |
Aetherium Acquisition A | GMFI | Aug 30, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Aug 30, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Aug 30, 2024 | 0.38 | -7.20 |
Aeva Technologies | AEVA | Aug 30, 2024 | 3.30 | +0.61 |
AEye A | LIDR | Aug 30, 2024 | 1.25 | 0.00 |
AFC Gamma | AFCG | Aug 30, 2024 | 10.46 | +0.29 |
Affiliated Managers Group | AMG | Aug 30, 2024 | 173.83 | +0.28 |
Affimed N.V. | AFMD | Aug 30, 2024 | 4.23 | -4.30 |
Affinity Bancshares | AFBI | Aug 30, 2024 | 21.34 | 0.00 |
Affirm A | AFRM | Aug 30, 2024 | 44.01 | +5.64 |
Aflac | AFL | Aug 30, 2024 | 110.36 | +0.67 |
Africa Index ETF Market Vectors | AFK | Aug 30, 2024 | 16.35 | -0.55 |
African Agriculture | AAGR | Aug 30, 2024 | 0.13 | -1.63 |
Afya A | AFYA | Aug 30, 2024 | 16.30 | -5.78 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.